Evidence map›Paper›PMID 28190238›Full record

ArticleMolecular neurobiology2018

Alpha-Synuclein Suppresses Retinoic Acid-Induced Neuronal Differentiation by Targeting the Glycogen Synthase Kinase-3β/β-Catenin Signaling Pathway.

Sasuk Kim, Juhee Lim, Yeojin Bang, Jisook Moon, Min-Soo Kwon, Jin Tae Hong, Jeha Jeon, Hyemyung Seo, Hyun Jin Choi

Expression of concernAbstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It carries an expression of concern. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Schizandrol A protects against AβNaunyn-Schmiedeberg's archives of pharmacology · 2020
    Article
  8. Dietary Antioxidants and Parkinson's Disease.Antioxidants (Basel, Switzerland) · 2020
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Sasuk KimCollege of Pharmacy and Institute of Pharmaceutical Sciences, CHA University, Seongnam, 13488, Republic of Korea.
Juhee LimCollege of Pharmacy and Institute of Pharmaceutical Sciences, CHA University, Seongnam, 13488, Republic of Korea.
Yeojin BangCollege of Pharmacy and Institute of Pharmaceutical Sciences, CHA University, Seongnam, 13488, Republic of Korea.
Jisook MoonDepartment of Bioengineering, College of Life Science, CHA University, Seongnam, 13488, Republic of Korea.
Min-Soo KwonDepartment of Pharmacology, School of Medicine, CHA University, Seongnam, 13488, Republic of Korea.
Jin Tae HongCollege of Pharmacy, Chungbuk National University, Cheongju, 28644, Republic of Korea.
Jeha JeonDepartment of Molecular and Life Sciences, Hanyang University, Ansan, 15588, Republic of Korea.
Hyemyung SeoDepartment of Molecular and Life Sciences, Hanyang University, Ansan, 15588, Republic of Korea.
Hyun Jin ChoiCollege of Pharmacy and Institute of Pharmaceutical Sciences, CHA University, Seongnam, 13488, Republic of Korea. hjchoi3@cha.ac.kr.
CHA University · KRHanyang University · KRChungbuk National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alpha-synuclein (α-SYN) is expressed during neuronal development and is mainly involved in the modulation of synaptic transmission. Missense mutations and amplifications of this gene have been associated with the pathogenesis of Parkinson's disease. Here, we evaluate whether α-SYN plays a detrimental role in the phenotypic and morphological regulation of neurons. We also identify the underlying mechanisms of this process in all-trans-retinoic acid (RA)-induced differentiated SH-SY5Y cells, which represents dopaminergic (DAergic) phenotype. Our results indicate that overexpression of wild-type or mutant A53T α-SYN attenuated the RA-induced upregulation of tyrosine hydroxylase and dopamine transporter as well as neurite outgrowth in SH-SY5Y cells. In addition, GSK-3β inactivation and downstream β-catenin stabilization were associated with RA-induced differentiation, which was attenuated by α-SYN. Moreover, protein phosphatase 2A was positively regulated by α-SYN and was implicated in the α-SYN-mediated interference with RA signaling. The results obtained from SH-SY5Y cells were verified in primary cultures of mesencephalic DAergic neurons from A53T α-SYN transgenic mice, which represent high levels of α-SYN and protein phosphatase 2A in the midbrain. The number and length of neurites in tyrosine hydroxylase-positive as well as Tau-positive cells from A53T α-SYN transgenic mice were significantly lower than those in littermate controls. The current results provide novel insight into the role of α-SYN in the regulation of neuronal differentiation, including DAergic neurons. Identifying the signaling pathway involved in the α-SYN-mediated dysregulation of neuronal differentiation could lead to a better understanding of the developmental processes underlying α-SYN-related pathologies and facilitate the discovery of specifically targeted therapeutics.

Indexed as

alpha-Synucleinbeta CateninCell DifferentiationCell Line, TumorDopamine Plasma Membrane Transport ProteinsGlycogen Synthase Kinase 3 betaHumansNeuritesNeuronsSignal TransductionTretinoinTyrosine 3-MonooxygenaseUp-Regulationalpha-Synucleinbeta CateninDopamine Plasma Membrane Transport ProteinsGlycogen Synthase Kinase 3 betaTretinoinTyrosine 3-MonooxygenaseDifferentiationDopaminergic neuronGSK-3βNeurite outgrowthα-Synucleinβ-Catenin

Identifiers

PMID28190238
OpenAlexW2587717115

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.